Response to Comment on: Targeting the acute phase of Peyronie's disease: Preliminary experience with Perovial®, a novel hyaluronic acid formulation.
- DOI
- 10.1038/s41443-026-01356-y
- Published
- 2026 Aug 25
- Container
- International journal of impotence research
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41443-026-01356-y,
title = {Response to Comment on: Targeting the acute phase of Peyronie's disease: Preliminary experience with Perovial®, a novel hyaluronic acid formulation.},
author = {Raffo M and Falcone M},
year = {2026},
journal = {International journal of impotence research},
doi = {10.1038/s41443-026-01356-y},
url = {https://doi.org/10.1038/s41443-026-01356-y}
}RIS
TY - JOUR TI - Response to Comment on: Targeting the acute phase of Peyronie's disease: Preliminary experience with Perovial®, a novel hyaluronic acid formulation. AU - Raffo M AU - Falcone M PY - 2026 JO - International journal of impotence research DO - 10.1038/s41443-026-01356-y UR - https://doi.org/10.1038/s41443-026-01356-y ER -
APA
M, R., & M, F. (2026). Response to Comment on: Targeting the acute phase of Peyronie's disease: Preliminary experience with Perovial®, a novel hyaluronic acid formulation.. International journal of impotence research. https://doi.org/10.1038/s41443-026-01356-y
Source records
- pubmed · retrieved 2026-09-26T23:56:58.479Z
- europe-pmc · retrieved 2026-09-26T23:56:58.490Z